Gastroenterology

[Comment] Metabolic syndrome myopathy: defining an emerging clinical entity in patients with MASLD | ClinicLens

Metabolic dysfunction-associated steatotic liver disease (MASLD) commonly coexists with poor muscle health, which encompasses three interconnected domains: muscle mass, muscle function, and muscle quality.1 We refer to this phenotype of impaired muscle health as metabolic syndrom

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.